@buchholzlab.bsky.socialTwo thumbs up for Annika Graser from our lab who presented two posters at two scientific meetings this month - at the CCE Summer School in Translational Cancer Research in Portugal and the DGHO Annual Meeting in Vienna. 👏
#DeutscheKrebshilfe #CAR-T #CellTherapy #CancerResearch #WomenInScience
@interestingpatents.bsky.socialCAR designs combine CD28H signaling with additional immune-signaling domains in T or NK cells for cancer treatment approaches.
Patent application: #US20260306544 | #HHS #CellTherapy
@siisdet.bsky.social🇲🇽 Dr. Pamela Violet Rodríguez Fardoe invites you. See you in Colombia!
📩 INFORMATION & REGISTRATION
🌐 siisdet.com
📧 [email protected]
📲 WhatsApp: +57 300 741 3546
#ICPRM2026 #SIISDET #RegenerativeMedicine #CellTherapy #ScientificResearch
@uchicagocancer.bsky.socialA first-of-its-kind clinical trial is testing a new type of personalized cell therapy designed to help the body's own immune system recognize and destroy cancer cells. https://ow.ly/P1m350ZXQU5 #CellTherapy #Immunotherapy #PersonalizedMedicine
@aktiego.bsky.socialHemostemix now has full Bahamian approval for its VesCell Phase 1 study, which was described as enrolling back in August while approvals were pending. Breakdown on aktiego.com.
Read more: aktiego.com/sectors/biot...
#TSXV #Biotech #CellTherapy #ClinicalTrials #BiotechNews #RegenerativeMedicine
@sigtrans-sttt.bsky.socialTo overcome tumor immune evasion, researchers engineered NK cells that target PD-L1, block NKG2A/HLA-E inhibitory signaling, and produce IL15 to improve antitumor activity, survival, and metabolic fitness.
#OpenAccess: doi.org/10.1038/s413...
#TumorImmunology #CellTherapy #ImmunoOncology
@drainteo.bsky.socialBetaLife 倍达生命科技 on Singapore 联合早报 111026!
We are a Stem Cell Therapy company, facilitating Beta Cell replacement, to create a Better Life for Diabetes patients. Continually seeking partners, supporters and funders!
#BetaLife #stemcells #betacells #diabetes #celltherapy #startup #Singapore
@achronicvoice.com"Adicet also noted that there were no serious cases of #cytokine release syndrome or.. #neurological #SideEffects, both of which are concerns with #CellTherapy treatments..intends to start up a pivotal study in #lupus in the 4th quarter.": buff.ly/U0s5mT3
via @biopharmadive.com
#MedSky #immunology
@gmj-georgia.bsky.social🔬 New hope for type 1 diabetes: First-in-human trial of immune-engineered cell therapy aims to replace daily insulin injections with a single transplant—… #Celltherapy #Clinicaltrial #Stemcells #Transplantation #Type1diabetes #Celltherapy #Clinicaltrial #Stemcells #Transplantation #Type1diabete…
@newsramp.comFamiCord's Bramble Bio has signed a manufacturing deal with VERIGRAFT to produce personalized tissue-engineered vein P-TEV for the pivotal Phase II/III trial TECVI-2, valued in the low single-digit millions of euros. Trial expected to begin Q1 2027. #CDMO #CellTherapy
@newsramp.comCreative Biolabs launches an AI-assisted CAR/TCR development platform integrating target discovery, construct engineering, and safety profiling to help researchers cut screening time and improve candidate selection. #CellTherapy #CART
@imtadvances.bsky.socialA simple whole-blood assay enables rapid, in vivo monitoring of engineered TCR T cell function, capturing cytokine responses post-transfer without complex processing. A practical step for tracking cell therapy performance. 🧬
@drtimos.bsky.social🧬 Gene & Cell Therapy | #RareDiseases 🚀
#LucidQuest delivers sharp insights to help biotechs, investors & BD teams stay ahead in fast-moving markets.
📩 [email protected] or http://dlvr.it/TVqbST
#GeneTherapy #CellTherapy #Biotech #DueDiligence #InvestmentInsights
@wileylifesci.bsky.socialPeacekeepers within your immune system, known as regulatory T cells, can now be reliably engineered in a lab.
This brings real hope for people with autoimmune disease and a greater chance of organ transplant success. #Immunology #CellTherapy
👉 Explore: https://bit.ly/3Thn8yA
@wileyhealth.bsky.socialPeacekeepers within your immune system, known as regulatory T cells, can now be reliably engineered in a lab.
This brings real hope for people with autoimmune disease and a greater chance of organ transplant success. #Immunology #CellTherapy
👉 Explore: https://bit.ly/4rERS9z
@imtadvances.bsky.socialA step forward in evolving cell therapies for AML: integrating TCR, CAR, BiTE, and safety switch into a single engineered T cell highlights how the field is moving toward multi-functional, adaptable designs to overcome tumor complexity.
@coherentcmi.bsky.socialStem Cell Banking Market: Size, Trends, Growth, and Strategic Outlook
www.coherentcmi.com/market-insig...
#CellTherapy #Biobanking #CordBloodBanking #CellBanking #Biotechnology #HealthcareTechnology #LifeSciences #HealthcareMarket #MarketResearch #GlobalMarket
@theebmt.bsky.social📣 The EBMT Trainee Committee is welcoming new members to join a collaborative team of early-career professionals and young haematologists.
🔎 Learn more about the opportunity to amplify your impact and make sure to apply by 6 November: ebmt.org/ebmt/news/ap...
@sigtrans-sttt.bsky.social
@sigtrans-sttt.bsky.socialCan gingiva-derived MSCs (GMSCs) help preserve β-cell function in #Type1Diabetes (#T1DM)? A phase 1 trial links GMSC therapy to improved residual β-cell function, potentially through CD8+ T-cell exhaustion.
#STTT #OpenAccess: doi.org/10.1038/s413...
#CellTherapy #BetaCellFunction
